Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Basel, Switzerland

About this trial

This study is to determine if a treatment target for a potential endovascular therapy exists in patients with an acute, spontaneous (non-traumatic) ICH.

Eligibility criteria

Qualifiers

Diagnosis of an acute spontaneous ICH based on non-contrast CT

Time from symptom onset to anticipated start of cerebral DSA of under 3 hours

Agreement of the treating physician to perform DSA

Informed consent documented by signature or fulfilling the criteria for emergency consent procedures (deferral of consent)

Disqualifiers

High probability that the etiology of the bleeding is a ruptured aneurysm, an arteriovenous malformation or an amyloid angiopathy as judged by the treating physician

Any time critical surgical or minimal invasive intervention is planned

Evidence of an ongoing pregnancy, a negative pregnancy test is mandatory in all persons of childbearing potential

Contraindications against the use of iodine contrast media

Trial design

Treatments tested in this trial

  • Diagnostic, cerebral Digital Subtraction Angiography (DSA)

Treatment groups

15 Participants
are divided into 1 treatment group

Sponsors and collaborators

University Hospital, Basel, Switzerland

Lead sponsor

Clinical Trial Unit, University Hospital Basel, Switzerland

Collaborator